Updated Nov. 17, 2012 at 10:51 a.m.

Premium Lock Tranzyme shares plunge another 16% after drug failure

Published: 2012-11-16 10:22:00
Updated: 2012-11-17 10:51:08

Print this blog post
Transzyme

Shares in Tranzyme Pharma plummeted 76 percent Thursday and another 16 percent after the RTP-based company announced failure of a drug that it hoped would treat diabetics suffering from gastroparesis....

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2013 WRAL Tech Wire. All rights reserved.

Please log in or register to view WRALTechWire Insider content


To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.

 1 Year Membership - 49.99 per year. Includes FREE unlimited access to online content, archives and discounts from Insider Partners. For less than $1 a week receive more than $900 in value.

 Monthly Membership - 4.99 per month. Includes FREE unlimited access every 30 days to online content only.

 Day Pass - 0.99 per day. Includes FREE unlimited access for 24 hours to online content only.

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Jim Roberts
Entrepreneurship
Frank Vinluan
Life science
Scroll